View ValuationINSAN 将来の成長Future 基準チェック /06現在、 INSANの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Personal Products 収益成長30.2%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • May 21First quarter 2026 earnings released: ₩9.00 loss per share (vs ₩7.00 loss in 1Q 2025)First quarter 2026 results: ₩9.00 loss per share (further deteriorated from ₩7.00 loss in 1Q 2025). Revenue: ₩9.99b (up 32% from 1Q 2025). Net loss: ₩331.9m (loss widened 26% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.New Risk • Mar 20New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.8% Last year net profit margin: 2.7% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.8% operating cash flow to total debt). Earnings have declined by 29% per year over the past 5 years. High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (1.8% net profit margin). Market cap is less than US$100m (₩42.5b market cap, or US$28.3m).Reported Earnings • Mar 20Full year 2025 earnings released: EPS: ₩17.00 (vs ₩23.00 in FY 2024)Full year 2025 results: EPS: ₩17.00 (down from ₩23.00 in FY 2024). Revenue: ₩35.8b (up 10% from FY 2024). Net income: ₩651.6m (down 27% from FY 2024). Profit margin: 1.8% (down from 2.7% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.お知らせ • Mar 06INSAN Inc., Annual General Meeting, Mar 24, 2026INSAN Inc., Annual General Meeting, Mar 24, 2026, at 11:00 Tokyo Standard Time. Location: conference room, 292-90, sambong-ro, hamyang-eup, hamyang-gun, gyeongsangnam-do, South KoreaUpcoming Dividend • Dec 22Upcoming dividend of ₩20.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. Payout ratio is on the higher end at 85% but the company is not cash flow positive. Trailing yield: 1.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.8%).New Risk • Nov 13New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (8.9% operating cash flow to total debt). Earnings have declined by 24% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₩44.9b market cap, or US$30.7m).Reported Earnings • Nov 13Third quarter 2025 earnings released: EPS: ₩33.00 (vs ₩2.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩33.00 (up from ₩2.00 in 3Q 2024). Revenue: ₩10.9b (up 17% from 3Q 2024). Net income: ₩1.24b (up 301% from 3Q 2024). Profit margin: 11% (up from 3.3% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.Declared Dividend • Nov 08Dividend of ₩20.00 announcedDividend of ₩20.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 13th April 2026 Dividend yield will be 1.7%, which is higher than the industry average of 1.2%. Sustainability & Growth Dividend is not covered by earnings (154% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 56 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 71% to bring the payout ratio under control. However, EPS has declined by 39% over the last 5 years so the company would need to reverse this trend.お知らせ • Nov 07INSAN Inc. announces Annual dividend, payable on April 13, 2026INSAN Inc. announced Annual dividend of KRW 20.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.New Risk • Aug 31New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 5.2% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.2% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 158% Paying a dividend despite having no free cash flows. Earnings have declined by 20% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.5% net profit margin). Market cap is less than US$100m (₩47.2b market cap, or US$34.0m).分析記事 • Jul 01Optimistic Investors Push INSAN Inc. (KOSDAQ:277410) Shares Up 26% But Growth Is LackingINSAN Inc. ( KOSDAQ:277410 ) shareholders have had their patience rewarded with a 26% share price jump in the last...Valuation Update With 7 Day Price Move • Jul 01Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩1,564, the stock trades at a trailing P/E ratio of 55.1x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 15% over the past three years.分析記事 • Jun 30Is INSAN (KOSDAQ:277410) A Risky Investment?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Mar 15Full year 2024 earnings released: EPS: ₩23.00 (vs ₩141 in FY 2023)Full year 2024 results: EPS: ₩23.00 (down from ₩141 in FY 2023). Revenue: ₩32.5b (down 13% from FY 2023). Net income: ₩887.5m (down 82% from FY 2023). Profit margin: 2.7% (down from 13% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.お知らせ • Feb 28INSAN Inc., Annual General Meeting, Mar 27, 2025INSAN Inc., Annual General Meeting, Mar 27, 2025, at 11:00 Tokyo Standard Time. Location: conference room, 292-90, sambong-ro, hamyang-gun, gyeongsangnam-do, South KoreaUpcoming Dividend • Dec 20Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 07 April 2025. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 3.6%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (1.1%).分析記事 • Dec 16Here's Why INSAN (KOSDAQ:277410) Has A Meaningful Debt BurdenHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...New Risk • Dec 03New major risk - Revenue and earnings growthEarnings have declined by 2.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 133% Paying a dividend despite having no free cash flows. Earnings have declined by 2.4% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.0% net profit margin). Market cap is less than US$100m (₩48.0b market cap, or US$34.2m).分析記事 • Mar 18INSAN (KOSDAQ:277410) Posted Healthy Earnings But There Are Some Other Factors To Be Aware OfINSAN Inc.'s ( KOSDAQ:277410 ) robust earnings report didn't manage to move the market for its stock. Our analysis...Reported Earnings • Mar 15Full year 2023 earnings released: EPS: ₩141 (vs ₩111 in FY 2022)Full year 2023 results: EPS: ₩141 (up from ₩111 in FY 2022). Revenue: ₩37.3b (up 11% from FY 2022). Net income: ₩4.97b (up 39% from FY 2022). Profit margin: 13% (up from 11% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per share at 2.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 05 April 2024. Payout ratio is a comfortable 30% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.2%).Reported Earnings • Nov 11Third quarter 2023 earnings released: EPS: ₩52.00 (vs ₩27.00 in 3Q 2022)Third quarter 2023 results: EPS: ₩52.00 (up from ₩27.00 in 3Q 2022). Revenue: ₩10.2b (up 18% from 3Q 2022). Net income: ₩1.97b (up 126% from 3Q 2022). Profit margin: 19% (up from 10.0% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.New Risk • Nov 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (10% net profit margin). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (₩72.8b market cap, or US$56.0m).Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₩2,680, the stock trades at a trailing P/E ratio of 26.8x. Average trailing P/E is 34x in the Personal Products industry in South Korea. Total returns to shareholders of 56% over the past three years.Valuation Update With 7 Day Price Move • Jun 29Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩2,570, the stock trades at a trailing P/E ratio of 25.7x. Average trailing P/E is 34x in the Personal Products industry in South Korea. Total returns to shareholders of 68% over the past three years.New Risk • Jun 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change). Profit margins are more than 30% lower than last year (10.0% net profit margin). Market cap is less than US$100m (₩82.5b market cap, or US$63.2m).Valuation Update With 7 Day Price Move • Jun 07Investor sentiment improves as stock rises 37%After last week's 37% share price gain to ₩2,550, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 27x in the Personal Products industry in South Korea. Total returns to shareholders of 50% over the past three years.Reported Earnings • Mar 16Full year 2022 earnings released: EPS: ₩117 (vs ₩209 in FY 2021)Full year 2022 results: EPS: ₩117 (down from ₩209 in FY 2021). Revenue: ₩33.5b (down 13% from FY 2021). Net income: ₩3.77b (down 40% from FY 2021). Profit margin: 11% (down from 17% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • Dec 21Upcoming dividend of ₩80.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 10 April 2023. Payout ratio is a comfortable 52% but the company is not cash flow positive. Trailing yield: 4.4%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (1.3%).Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₩209 (up from ₩177 in FY 2020). Revenue: ₩38.3b (up 26% from FY 2020). Net income: ₩6.33b (up 35% from FY 2020). Profit margin: 17% (up from 15% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₩2,570, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total returns to shareholders of 60% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 04 April 2022. Payout ratio is a comfortable 25% but the company is not cash flow positive. Trailing yield: 2.4%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (0.8%).Reported Earnings • Nov 11Third quarter 2021 earnings released: EPS ₩51.00 (vs ₩43.00 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₩9.94b (up 22% from 3Q 2020). Net income: ₩1.61b (up 41% from 3Q 2020). Profit margin: 16% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Apr 17Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₩2,515, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 24x in the Personal Products industry in South Korea. Total returns to shareholders of 79% over the past year.分析記事 • Apr 07Here's Why I Think INSAN (KOSDAQ:277410) Is An Interesting StockFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...分析記事 • Mar 16INSAN (KOSDAQ:277410) Has A Pretty Healthy Balance SheetDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • Mar 12Full year 2020 earnings released: EPS ₩177 (vs ₩121 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩30.5b (up 18% from FY 2019). Net income: ₩4.68b (up 50% from FY 2019). Profit margin: 15% (up from 12% in FY 2019). The increase in margin was driven by higher revenue.分析記事 • Feb 23Is INSAN Inc. (KOSDAQ:277410) A Great Dividend Stock?Is INSAN Inc. ( KOSDAQ:277410 ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...分析記事 • Feb 02We're Not So Sure You Should Rely on INSAN's (KOSDAQ:277410) Statutory EarningsIt might be old fashioned, but we really like to invest in companies that make a profit, each and every year. Having...Is New 90 Day High Low • Jan 29New 90-day low: ₩1,840The company is down 4.0% from its price of ₩1,925 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 18% over the same period.分析記事 • Jan 13What Do The Returns On Capital At INSAN (KOSDAQ:277410) Tell Us?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...Is New 90 Day High Low • Jan 11New 90-day low: ₩1,885The company is down 10.0% from its price of ₩2,085 on 13 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period.分析記事 • Dec 23Should You Be Adding INSAN (KOSDAQ:277410) To Your Watchlist Today?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Upcoming Dividend • Dec 22Upcoming Dividend of ₩30.00 Per ShareWill be paid on the 8th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.5% is below the top quartile of South Korean dividend payers (2.6%), but it is higher than industry peers (0.6%).分析記事 • Dec 02Is INSAN (KOSDAQ:277410) A Risky Investment?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Is New 90 Day High Low • Oct 07New 90-day high: ₩2,090The company is up 24% from its price of ₩1,685 on 09 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 7.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、INSAN は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測KOSDAQ:A277410 - アナリストの将来予測と過去の財務データ ( )KRW Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202638,212583-17,2002,227N/A12/31/202535,804652-18,3061,171N/A9/30/202535,0261,422-16,6993,600N/A6/30/202533,444491-15,2441,779N/A3/31/202532,7261,069-15,561735N/A12/31/202432,484887-14,200-987N/A9/30/202434,7011,628-8,3071,421N/A6/30/202435,5703,286-3,5722,321N/A3/31/202437,1034,3493,2226,047N/A12/31/202337,3004,9694,0847,147N/A9/30/202334,9834,248-932,670N/A6/30/202333,4623,152-3,9442,028N/A3/31/202332,4823,031-10,772119N/A12/31/202233,5383,580-11,430149N/A9/30/202237,4554,935-6,9396,376N/A6/30/202238,6885,673-5,6465,325N/A3/31/202239,3056,323-3,9738,153N/A12/31/202138,3086,327-2,6749,467N/A9/30/202135,2255,894-8,3727,031N/A6/30/202133,4175,427-7,8908,752N/A3/31/202131,2134,431-8,7065,883N/A12/31/202030,4654,682-9,5425,686N/A9/30/202028,6553,841-5,5425,246N/A6/30/202028,0444,217-2,5745,101N/A3/31/202027,3464,067-1,4534,599N/A12/31/201925,8643,130N/A3,794N/A9/30/201925,7452,330N/A3,945N/A6/30/201925,210-1,046N/A2,955N/A3/31/201924,871-1,351N/A3,136N/A12/31/201825,232-951N/A2,764N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: A277410の予測収益成長が 貯蓄率 ( 3.1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: A277410の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: A277410の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: A277410の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: A277410の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: A277410の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHousehold 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/17 11:14終値2026/06/17 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋INSAN Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 21First quarter 2026 earnings released: ₩9.00 loss per share (vs ₩7.00 loss in 1Q 2025)First quarter 2026 results: ₩9.00 loss per share (further deteriorated from ₩7.00 loss in 1Q 2025). Revenue: ₩9.99b (up 32% from 1Q 2025). Net loss: ₩331.9m (loss widened 26% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.
New Risk • Mar 20New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.8% Last year net profit margin: 2.7% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.8% operating cash flow to total debt). Earnings have declined by 29% per year over the past 5 years. High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (1.8% net profit margin). Market cap is less than US$100m (₩42.5b market cap, or US$28.3m).
Reported Earnings • Mar 20Full year 2025 earnings released: EPS: ₩17.00 (vs ₩23.00 in FY 2024)Full year 2025 results: EPS: ₩17.00 (down from ₩23.00 in FY 2024). Revenue: ₩35.8b (up 10% from FY 2024). Net income: ₩651.6m (down 27% from FY 2024). Profit margin: 1.8% (down from 2.7% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 06INSAN Inc., Annual General Meeting, Mar 24, 2026INSAN Inc., Annual General Meeting, Mar 24, 2026, at 11:00 Tokyo Standard Time. Location: conference room, 292-90, sambong-ro, hamyang-eup, hamyang-gun, gyeongsangnam-do, South Korea
Upcoming Dividend • Dec 22Upcoming dividend of ₩20.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. Payout ratio is on the higher end at 85% but the company is not cash flow positive. Trailing yield: 1.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.8%).
New Risk • Nov 13New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (8.9% operating cash flow to total debt). Earnings have declined by 24% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₩44.9b market cap, or US$30.7m).
Reported Earnings • Nov 13Third quarter 2025 earnings released: EPS: ₩33.00 (vs ₩2.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩33.00 (up from ₩2.00 in 3Q 2024). Revenue: ₩10.9b (up 17% from 3Q 2024). Net income: ₩1.24b (up 301% from 3Q 2024). Profit margin: 11% (up from 3.3% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
Declared Dividend • Nov 08Dividend of ₩20.00 announcedDividend of ₩20.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 13th April 2026 Dividend yield will be 1.7%, which is higher than the industry average of 1.2%. Sustainability & Growth Dividend is not covered by earnings (154% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 56 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 71% to bring the payout ratio under control. However, EPS has declined by 39% over the last 5 years so the company would need to reverse this trend.
お知らせ • Nov 07INSAN Inc. announces Annual dividend, payable on April 13, 2026INSAN Inc. announced Annual dividend of KRW 20.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
New Risk • Aug 31New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 5.2% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.2% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 158% Paying a dividend despite having no free cash flows. Earnings have declined by 20% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.5% net profit margin). Market cap is less than US$100m (₩47.2b market cap, or US$34.0m).
分析記事 • Jul 01Optimistic Investors Push INSAN Inc. (KOSDAQ:277410) Shares Up 26% But Growth Is LackingINSAN Inc. ( KOSDAQ:277410 ) shareholders have had their patience rewarded with a 26% share price jump in the last...
Valuation Update With 7 Day Price Move • Jul 01Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩1,564, the stock trades at a trailing P/E ratio of 55.1x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 15% over the past three years.
分析記事 • Jun 30Is INSAN (KOSDAQ:277410) A Risky Investment?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Mar 15Full year 2024 earnings released: EPS: ₩23.00 (vs ₩141 in FY 2023)Full year 2024 results: EPS: ₩23.00 (down from ₩141 in FY 2023). Revenue: ₩32.5b (down 13% from FY 2023). Net income: ₩887.5m (down 82% from FY 2023). Profit margin: 2.7% (down from 13% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 28INSAN Inc., Annual General Meeting, Mar 27, 2025INSAN Inc., Annual General Meeting, Mar 27, 2025, at 11:00 Tokyo Standard Time. Location: conference room, 292-90, sambong-ro, hamyang-gun, gyeongsangnam-do, South Korea
Upcoming Dividend • Dec 20Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 07 April 2025. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 3.6%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (1.1%).
分析記事 • Dec 16Here's Why INSAN (KOSDAQ:277410) Has A Meaningful Debt BurdenHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
New Risk • Dec 03New major risk - Revenue and earnings growthEarnings have declined by 2.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 133% Paying a dividend despite having no free cash flows. Earnings have declined by 2.4% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.0% net profit margin). Market cap is less than US$100m (₩48.0b market cap, or US$34.2m).
分析記事 • Mar 18INSAN (KOSDAQ:277410) Posted Healthy Earnings But There Are Some Other Factors To Be Aware OfINSAN Inc.'s ( KOSDAQ:277410 ) robust earnings report didn't manage to move the market for its stock. Our analysis...
Reported Earnings • Mar 15Full year 2023 earnings released: EPS: ₩141 (vs ₩111 in FY 2022)Full year 2023 results: EPS: ₩141 (up from ₩111 in FY 2022). Revenue: ₩37.3b (up 11% from FY 2022). Net income: ₩4.97b (up 39% from FY 2022). Profit margin: 13% (up from 11% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per share at 2.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 05 April 2024. Payout ratio is a comfortable 30% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.2%).
Reported Earnings • Nov 11Third quarter 2023 earnings released: EPS: ₩52.00 (vs ₩27.00 in 3Q 2022)Third quarter 2023 results: EPS: ₩52.00 (up from ₩27.00 in 3Q 2022). Revenue: ₩10.2b (up 18% from 3Q 2022). Net income: ₩1.97b (up 126% from 3Q 2022). Profit margin: 19% (up from 10.0% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
New Risk • Nov 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (10% net profit margin). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (₩72.8b market cap, or US$56.0m).
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₩2,680, the stock trades at a trailing P/E ratio of 26.8x. Average trailing P/E is 34x in the Personal Products industry in South Korea. Total returns to shareholders of 56% over the past three years.
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩2,570, the stock trades at a trailing P/E ratio of 25.7x. Average trailing P/E is 34x in the Personal Products industry in South Korea. Total returns to shareholders of 68% over the past three years.
New Risk • Jun 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change). Profit margins are more than 30% lower than last year (10.0% net profit margin). Market cap is less than US$100m (₩82.5b market cap, or US$63.2m).
Valuation Update With 7 Day Price Move • Jun 07Investor sentiment improves as stock rises 37%After last week's 37% share price gain to ₩2,550, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 27x in the Personal Products industry in South Korea. Total returns to shareholders of 50% over the past three years.
Reported Earnings • Mar 16Full year 2022 earnings released: EPS: ₩117 (vs ₩209 in FY 2021)Full year 2022 results: EPS: ₩117 (down from ₩209 in FY 2021). Revenue: ₩33.5b (down 13% from FY 2021). Net income: ₩3.77b (down 40% from FY 2021). Profit margin: 11% (down from 17% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • Dec 21Upcoming dividend of ₩80.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 10 April 2023. Payout ratio is a comfortable 52% but the company is not cash flow positive. Trailing yield: 4.4%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (1.3%).
Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₩209 (up from ₩177 in FY 2020). Revenue: ₩38.3b (up 26% from FY 2020). Net income: ₩6.33b (up 35% from FY 2020). Profit margin: 17% (up from 15% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₩2,570, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total returns to shareholders of 60% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 04 April 2022. Payout ratio is a comfortable 25% but the company is not cash flow positive. Trailing yield: 2.4%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (0.8%).
Reported Earnings • Nov 11Third quarter 2021 earnings released: EPS ₩51.00 (vs ₩43.00 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₩9.94b (up 22% from 3Q 2020). Net income: ₩1.61b (up 41% from 3Q 2020). Profit margin: 16% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Apr 17Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₩2,515, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 24x in the Personal Products industry in South Korea. Total returns to shareholders of 79% over the past year.
分析記事 • Apr 07Here's Why I Think INSAN (KOSDAQ:277410) Is An Interesting StockFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
分析記事 • Mar 16INSAN (KOSDAQ:277410) Has A Pretty Healthy Balance SheetDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • Mar 12Full year 2020 earnings released: EPS ₩177 (vs ₩121 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩30.5b (up 18% from FY 2019). Net income: ₩4.68b (up 50% from FY 2019). Profit margin: 15% (up from 12% in FY 2019). The increase in margin was driven by higher revenue.
分析記事 • Feb 23Is INSAN Inc. (KOSDAQ:277410) A Great Dividend Stock?Is INSAN Inc. ( KOSDAQ:277410 ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...
分析記事 • Feb 02We're Not So Sure You Should Rely on INSAN's (KOSDAQ:277410) Statutory EarningsIt might be old fashioned, but we really like to invest in companies that make a profit, each and every year. Having...
Is New 90 Day High Low • Jan 29New 90-day low: ₩1,840The company is down 4.0% from its price of ₩1,925 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 18% over the same period.
分析記事 • Jan 13What Do The Returns On Capital At INSAN (KOSDAQ:277410) Tell Us?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
Is New 90 Day High Low • Jan 11New 90-day low: ₩1,885The company is down 10.0% from its price of ₩2,085 on 13 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period.
分析記事 • Dec 23Should You Be Adding INSAN (KOSDAQ:277410) To Your Watchlist Today?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩30.00 Per ShareWill be paid on the 8th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.5% is below the top quartile of South Korean dividend payers (2.6%), but it is higher than industry peers (0.6%).
分析記事 • Dec 02Is INSAN (KOSDAQ:277410) A Risky Investment?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Is New 90 Day High Low • Oct 07New 90-day high: ₩2,090The company is up 24% from its price of ₩1,685 on 09 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 7.0% over the same period.